Probiotic pill shows promise for gut inflammation in early trial

NCT ID NCT05666960

First seen Feb 01, 2026 · Last updated May 13, 2026 · Updated 19 times

Summary

This early-stage study is testing a probiotic pill called R-3750 in 36 adults with mild to moderate ulcerative colitis. The main goal is to see if the pill is safe and tolerable. Participants will take the probiotic by mouth and report their symptoms, while researchers check blood and stool for signs of inflammation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AP Medical Research LLC

    RECRUITING

    Miami, Florida, 33165, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Amicis Research Center

    RECRUITING

    Valencia, California, 91355, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Edward Jenner Research Group, LLC

    RECRUITING

    Plantation, Florida, 33317, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Mayo Clinic

    RECRUITING

    Rochester, Minnesota, 55902, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.